High Rate of Glycolysis and Cancer

K-J Tian
{"title":"High Rate of Glycolysis and Cancer","authors":"K-J Tian","doi":"10.4172/1948-5956.1000531","DOIUrl":null,"url":null,"abstract":"One hundred years ago, abnormal metabolism of cancer cell was regarded as one of the most important pathological features of malignancy. Recently, with the development of system biology, researchers regained the interest in regulating cancer metabolism. In 1920s’, Dr. Otto Warburg discovered that, even when oxygen is ample, malignant cells still prefer the anaerobic glycolysis, and the rate of glucose uptake is high while the overall glycolysis increases. Cancer cells divide faster than normal cells, hence they need more bioenergy, and they need to change their metabolism to produce the extra energy. In recent 20 years, the link between high rate of glycolysis and cancer was re-evaluated and has inspired enthusiasm upon research into the metabolism of cancer cells. Novel diagnostic methods and new drugs were created by the understanding of the features of cancer metabolism. Glycolysis in cancer cells has clinical implications in cancer diagnosis, treatment and prognosis. The purpose of this review is to focus on the mechanism of high rate of glycolysis in cancer and its significance in cancer diagnosis and therapies. The regulatory network of cancer is complex, system biology might help us to find the clue. There are evidences showing that mixture of drugs has therapeutic advantages in clinical practice. Combinations of anti-neoplasm drugs have already been administered with encouraging results. Therefore, the multi-targeted MCA advised therapy might be the most promising strategy for cancer. The study for novel inhibitors from medicinal herbs are now ongoing. We believe, there will be more and more therapeutic strategies coming in the near future to help human beings fighting with cancer.","PeriodicalId":15170,"journal":{"name":"Journal of Cancer Science & Therapy","volume":"31 1","pages":"140-142"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Science & Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/1948-5956.1000531","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

One hundred years ago, abnormal metabolism of cancer cell was regarded as one of the most important pathological features of malignancy. Recently, with the development of system biology, researchers regained the interest in regulating cancer metabolism. In 1920s’, Dr. Otto Warburg discovered that, even when oxygen is ample, malignant cells still prefer the anaerobic glycolysis, and the rate of glucose uptake is high while the overall glycolysis increases. Cancer cells divide faster than normal cells, hence they need more bioenergy, and they need to change their metabolism to produce the extra energy. In recent 20 years, the link between high rate of glycolysis and cancer was re-evaluated and has inspired enthusiasm upon research into the metabolism of cancer cells. Novel diagnostic methods and new drugs were created by the understanding of the features of cancer metabolism. Glycolysis in cancer cells has clinical implications in cancer diagnosis, treatment and prognosis. The purpose of this review is to focus on the mechanism of high rate of glycolysis in cancer and its significance in cancer diagnosis and therapies. The regulatory network of cancer is complex, system biology might help us to find the clue. There are evidences showing that mixture of drugs has therapeutic advantages in clinical practice. Combinations of anti-neoplasm drugs have already been administered with encouraging results. Therefore, the multi-targeted MCA advised therapy might be the most promising strategy for cancer. The study for novel inhibitors from medicinal herbs are now ongoing. We believe, there will be more and more therapeutic strategies coming in the near future to help human beings fighting with cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高糖酵解率与癌症
一百年前,癌细胞代谢异常被认为是恶性肿瘤最重要的病理特征之一。近年来,随着系统生物学的发展,研究人员对调节肿瘤代谢重新产生了兴趣。在20世纪20年代,Otto Warburg博士发现,即使在氧气充足的情况下,恶性细胞仍然倾向于厌氧糖酵解,并且糖酵解的整体增加,葡萄糖的摄取率也很高。癌细胞比正常细胞分裂得快,因此它们需要更多的生物能量,它们需要改变自己的新陈代谢来产生额外的能量。近20年来,高糖酵解率与癌症之间的关系被重新评估,激发了对癌细胞代谢研究的热情。对肿瘤代谢特征的认识,创造了新的诊断方法和新药。肿瘤细胞糖酵解对肿瘤的诊断、治疗和预后具有重要的临床意义。本文就糖酵解在肿瘤中的高速率机制及其在肿瘤诊断和治疗中的意义进行综述。癌症的调控网络是复杂的,系统生物学可能会帮助我们找到线索。在临床实践中,有证据表明混合用药具有治疗优势。联合使用抗肿瘤药物已经取得了令人鼓舞的结果。因此,多靶点MCA建议治疗可能是最有希望的癌症治疗策略。从草药中提取新型抑制剂的研究正在进行中。我们相信,在不久的将来会有越来越多的治疗策略来帮助人类与癌症作斗争。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Role of Oxygen and Nitrogen Radicals in the Mechanism of Anticancer Drug Cytotoxicity. Durable Response to Immune Checkpoint Blockade Plus Albumin-Bound Paclitaxel in Two Osimertinib-Refractory Patients with EGFR-mutated Lung Adenocarcinoma Significant Role of MCM10 in Lung Adenocarcinoma: Promote Viability and Migration Cisplatin-Based Chemotherapy of Human Cancers FLOT1 is a novel target of ovarian cancer for diagnosis and treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1